Skin-patch COVID-19 vaccine could offer enhanced antibody responses, according to preclinical data
COVID-19 vaccination via Vaxxas’ novel high-density microarray patch showed 'significantly enhanced' T-cell and spike-specific antibody responses compared to needle delivery, according to a pre-print preclinical study published this week.
